Background Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple systems and organs. Its pathogenesis has not been entirely elucidated.

研究背景系统性红斑狼疮(SLE)是一种临床表现多样化、可累及多个系统的自身免疫性疾病。

youdao

Genentech and Biogen Idec said Tuesday that a key study of the drug Rituxan did not meet its main goal of a response in patients with systemic lupus erythematosus, commonly called lupus.

FORBES: Magazine Article

Genentech (nyse: DNA - news - people ) and Biogen Idec (nasdaq: BIIB - news - people ) said Tuesday that a key study of the drug Rituxan did not meet its main goal of a response in patients with systemic lupus erythematosus, commonly called lupus.

FORBES: Lupus Treatment Evades Genentech, Biogen